11 insiders reported 151 Form 4 transactions for RECURSION PHARMACEUTICALS, INC. (RXRX) over the past 18 months (most recent 2026-07-02). Recent activity: Li Dean Y (Director) Buy 3,747 shares, Dar Zavain (Director) Buy 5,109 shares, HERSHBERG ROBERT (Director) Buy 88,424 shares, Sun Elaine D (Director) Buy 88,424 shares, Li Dean Y (Director) Buy 88,424 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Li Dean Y | Director | Buy | 3,747 | $0 |
| 2026-07-02 | Dar Zavain | Director | Buy | 5,109 | $0 |
| 2026-06-22 | HERSHBERG ROBERT | Director | Buy | 88,424 | $0 |
| 2026-06-22 | Sun Elaine D | Director | Buy | 88,424 | $0 |
| 2026-06-22 | Li Dean Y | Director | Buy | 88,424 | $0 |
| 2026-06-22 | Dar Zavain | Director | Buy | 88,424 | $0 |
| 2026-06-22 | Borgeson Blake | Director | Buy | 88,424 | $0 |
| 2026-06-22 | Michor Franziska | Director | Buy | 88,424 | $0 |
| 2026-06-22 | Bumpus Namandje | Director | Buy | 88,424 | $0 |
| 2026-06-22 | Bumpus Namandje | Director | Sell | 3,963 | $12,602 |
| 2026-06-17 | Taylor Ben R | Chief Financial Officer | Sell | 5,396 | $16,997 |
| 2026-06-05 | Gibson Christopher | Director | Sell | 40,000 | $144,800 |
| 2026-06-05 | Khan Najat | CEO and President | Sell | 23,588 | $84,459 |
| 2026-06-05 | Gibson Christopher | Director | Buy | 40,000 | $0 |
| 2026-05-19 | Khan Najat | CEO and President | Sell | 62,701 | $190,611 |
| 2026-05-19 | Taylor Ben R | Chief Financial Officer | Sell | 25,018 | $76,055 |
| 2026-05-19 | Gibson Christopher | Director | Sell | 22,821 | $69,376 |
| 2026-05-19 | Hallett David | Chief Scientific Officer | Sell | 26,657 | $81,037 |
| 2026-05-08 | Gibson Christopher | Director | Buy | 60,000 | $0 |
| 2026-05-08 | Gibson Christopher | Director | Sell | 40,000 | $134,800 |
| 2026-05-08 | Gibson Christopher | Director | Sell | 20,000 | $0 |
| 2026-05-07 | Borgeson Blake | Director | Sell | 30,000 | $105,600 |
| 2026-04-24 | Gibson Christopher | Director | Buy | 40,000 | $0 |
| 2026-04-24 | Gibson Christopher | Director | Sell | 40,000 | $144,400 |
| 2026-04-08 | Taylor Ben R | Chief Financial Officer | Sell | 48,028 | $149,367 |
Source: SEC Form 4 filings · as of 2026-07-02